EXACTICS Trademark

Trademark Overview


On Tuesday, October 22, 2024, a trademark application was filed for EXACTICS with the United States Patent and Trademark Office. The USPTO has given the EXACTICS trademark a serial number of 98813231. The federal status of this trademark filing is NEW APPLICATION - ASSIGNED TO EXAMINER as of Tuesday, March 25, 2025. This trademark is owned by Exactics, LLC. The EXACTICS trademark is filed in the Pharmaceutical Products category with the following description:

Diagnostic kits comprised of medical diagnostic reagents and assays for testing of bodily fluids for use in disease detection, namely, malaria, dengue fever, hemorrhagic fevers (including Ebola, crimean-congo hemorrhagic fever), Lassa fever, Lymphatic filariasis, Zika virus, rocky mountain spotted fever, sexually transmitted diseases (STDs), sexually transmitted infections (STIs), Alpha-gal, arthropod-borne diseases, parasitic diseases, bacterial diseases, viral diseases, diseases causing autoimmune disorders, respiratory diseases, fungal diseases, prion diseases, neurological diseases, endocrine diseases, hematologic diseases, oncological diseases, metabolic diseases, genetic diseases, cardiovascular diseases, dermatological diseases, renal diseases, gastrointestinal diseases, musculoskeletal diseases, allergic diseases, occupational diseases, nutritional diseases, psychiatric/mental health disorders, developmental disorders, traumatic diseases/injuries, environmental diseases, immuno...
exactics

General Information


Serial Number98813231
Word MarkEXACTICS
Filing DateTuesday, October 22, 2024
Status638 - NEW APPLICATION - ASSIGNED TO EXAMINER
Status DateTuesday, March 25, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and ServicesDiagnostic kits comprised of medical diagnostic reagents and assays for testing of bodily fluids for use in disease detection, namely, malaria, dengue fever, hemorrhagic fevers (including Ebola, crimean-congo hemorrhagic fever), Lassa fever, Lymphatic filariasis, Zika virus, rocky mountain spotted fever, sexually transmitted diseases (STDs), sexually transmitted infections (STIs), Alpha-gal, arthropod-borne diseases, parasitic diseases, bacterial diseases, viral diseases, diseases causing autoimmune disorders, respiratory diseases, fungal diseases, prion diseases, neurological diseases, endocrine diseases, hematologic diseases, oncological diseases, metabolic diseases, genetic diseases, cardiovascular diseases, dermatological diseases, renal diseases, gastrointestinal diseases, musculoskeletal diseases, allergic diseases, occupational diseases, nutritional diseases, psychiatric/mental health disorders, developmental disorders, traumatic diseases/injuries, environmental diseases, immunodeficiency diseases, congenital diseases, reproductive diseases, hepatic diseases, occular diseases, oral and dental diseases, urological diseases, aging-related diseases; Diagnostic kits consisting primarily of monoclonal antibodies, buffers, and reagents for use in disease testing

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, October 22, 2024
Primary Code005
First Use Anywhere DateFriday, September 17, 2021
First Use In Commerce DateTuesday, July 16, 2024

Trademark Owner History


Party NameExactics, LLC
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressManchester, CT 06040

Trademark Events


Event DateEvent Description
Tuesday, October 22, 2024NEW APPLICATION ENTERED
Tuesday, October 22, 2024APPLICATION FILING RECEIPT MAILED
Tuesday, March 25, 2025ASSIGNED TO EXAMINER
Tuesday, October 22, 2024NEW APPLICATION OFFICE SUPPLIED DATA ENTERED